Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma

BACKGROUND: Bendamustine is an attractive option for the management of both de novo and relapsed lymphomas. It is being increasingly used in the conditioning regimen for autologous stem cell transplantation (SCT) and can be an alternative to the traditionally-used carmustine. In this study, we aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabbir-Moosajee, Munira, Jehangir, Samad, Sawani, Sobiya, Muhammed, Tariq, Ali, Natasha, Sheikh, Usman, Adil, Salman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614092/
https://www.ncbi.nlm.nih.gov/pubmed/31309088
http://dx.doi.org/10.5045/br.2019.54.2.108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614092/
https://www.ncbi.nlm.nih.gov/pubmed/31309088
http://dx.doi.org/10.5045/br.2019.54.2.108

Ejemplares similares